Form 4 for AYTU AYTU BIOPHARMA, INC
Accepted 2022-11-21 00:00:00 ET · period of report 2022-11-18 · accession 0001654954-22-015598 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-21 | 2022-11-18 | AYTU | Oki Mark K | CFO | A - Grant | $0.23 | +90.0K | 190.0K | +90% | +$20.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-11-18 | A | A | 90,000 | $0.23 | 190,000 | D | — | — |